Provided by Tiger Trade Technology Pte. Ltd.

Warren Buffett holdings

3,201.57
+28.500.90%
Number of Gainers:25
Number of Losers:10
Number of Flat:- -
PE:- -
High:3,216.92
Open:3,182.15
Low:3,182.15
Close:3,173.07
Volume:233.41M
Turnover:36.89B
Market Cap:11.41T
Float Cap:10.80T

Loading ...

Biotech Stocks Jump Premarket After Moderna's Melanoma Vaccine with Merck Succeeds in Large Trial

THOMSON REUTERS
·
Aug 19

Fed Minutes on Tap Tonight as Shandong Gold Tops A-Share Inflow Charts, Huabao Fund Flags Metals Opportunity

Deep News
·
Aug 19

The Bond Selloff is Rattling Investors, but Here's Why They Shouldn't Expect a Deeper Stock Downturn

Dow Jones
·
Aug 19

Apple's EU App Developer Terms are 'Missed Opportunity,' Lobby Group Says

Dow Jones
·
Aug 19

Stocks to Watch: Oracle, SK Hynix, Moderna, Unitree

Dow Jones
·
Aug 19

Moderna, Merck, La-Z-Boy, SK Hynix, and More Stocks That Explain Today's Market

Dow Jones
·
Aug 19

U.S. Stocks on the MOVE-Estee Lauder, Target, Analog Devices

Reuters
·
Aug 19

Merck, Moderna Say Potential Melanoma Therapy Shows 'Statistically Significant Improvement' in Late-Stage Trial

MT Newswires Live
·
Aug 19

Bond Yields, Persian Gulf Outlooks Cap Wall Street Pre-Bell; Asia, Europe Off

MT Newswires Live
·
Aug 19

Zeta Global Holdings Corp (ZETA) Receives a Buy from Bank of America Securities

TIPRANKS
·
Aug 19

Analysts Offer Insights on Technology Companies: Snowflake (SNOW), Coherent Corp (COHR) and Amplitude (AMPL)

TIPRANKS
·
Aug 19

Moderna Stock Surges 70%, Merck Rises 6%. at Last, a Successful Cancer Vaccine.

Dow Jones
·
Aug 19

META, MSFT and AMZN Face Rising Costs and Delays as AI Data Center Backlash Grows

TIPRANKS
·
Aug 19

Moderna and Merck Say Melanoma Skin Cancer Vaccine Meets Goals in Large Trial

Reuters
·
Aug 19

Moderna Vaccine Cuts Recurrence and Spread of High-Risk Melanoma, Raising New Treatment Hope

Reuters
·
Aug 19

Liquidia Technologies (LQDA) Gets a Buy from Wells Fargo

TIPRANKS
·
Aug 19

Merck Shares Rise 1.9% Premarket

THOMSON REUTERS
·
Aug 19

Merck, Moderna Say Melanoma Skin Cancer Vaccine Meets Goals in Large Trial

Reuters
·
Aug 19

Merck: Safety Profiles of Intismeran and Keytruda in Trial were Consistent with Prior Reported Studies for the Combination

THOMSON REUTERS
·
Aug 19

Merck: Phase 3 Interpath-001 Trial of Intismeran Autogene Plus Keytruda Met Primary Endpoint of Recurrence Free Survival

THOMSON REUTERS
·
Aug 19